Atlas Trials

A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain.

Clinical trial NCT00261495 · COMPLETED

Trial details

NCT number
NCT00261495
Sponsor
Janssen Pharmaceutica N.V., Belgium
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pain
Start date
2006-03-01
Primary completion
2008-04-01
Enrollment
504

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.